amantadine has been researched along with olanzapine in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (60.00) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Deberdt, W; Floris, M; Lejeune, J | 1 |
Bahk, WM; Chae, JH; Jun, T; Kim, KS; Lee, KU; Pae, CU | 1 |
Breier, A; Bymaster, FP; Carlson, CD; Cavazzoni, PA; Deberdt, W; Floris, M; Trzaskoma, QN; Wiener, K; Winokur, A | 1 |
Graham, KA; Gu, H; Harp, JB; Lieberman, JA; Perkins, DO | 1 |
Heinloth, AN; Hoffmann, VP; Kinon, BJ; Lipkovich, I; McGregor, HS; Stauffer, VL | 1 |
Case, M; Hoffmann, VP; Jacobson, JG | 1 |
Buchmann, J; Häßler, F; Höppner, J; Pohl, B; Reis, O; Weirich, S | 1 |
Dutta, A; Rana, S; Talukdar, A; Talukdar, P | 1 |
1 review(s) available for amantadine and olanzapine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for amantadine and olanzapine
Article | Year |
---|---|
Effect of amantadine on weight gain during olanzapine treatment.
Topics: Adult; Amantadine; Antipsychotic Agents; Benzodiazepines; Dopamine Agents; Female; Humans; Male; Olanzapine; Pirenzepine; Psychotic Disorders; Weight Gain | 2001 |
Open label study of the effect of amantadine on weight gain induced by olanzapine.
Topics: Adult; Amantadine; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Brief Psychiatric Rating Scale; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neurologic Examination; Olanzapine; Psychotic Disorders; Schizophrenia; Treatment Outcome | 2004 |
Amantadine for weight gain associated with olanzapine treatment.
Topics: Adolescent; Adult; Aged; Amantadine; Analysis of Variance; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Brief Psychiatric Rating Scale; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Time Factors; Treatment Outcome; Weight Gain | 2005 |
Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine.
Topics: Amantadine; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Dopamine Agents; Double-Blind Method; Female; Humans; Male; Obesity; Olanzapine; Placebos; Schizophrenia; Treatment Outcome; Weight Loss | 2005 |
Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study.
Topics: Adolescent; Adult; Aged; Algorithms; Amantadine; Antipsychotic Agents; Benzodiazepines; Clinical Protocols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Metformin; Middle Aged; Olanzapine; Psychotic Disorders; Schizophrenia; Weight Gain; Zonisamide | 2012 |
9 other study(ies) available for amantadine and olanzapine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis.
Topics: Adult; Amantadine; Appetite; Benzodiazepines; Bipolar Disorder; Cognition Disorders; Cyclobutanes; Drug Therapy, Combination; Feeding Behavior; Female; Humans; Male; Nizatidine; Olanzapine; Randomized Controlled Trials as Topic; Schizophrenia; Weight Gain; Weight Loss | 2009 |
A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy.
Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Combined Modality Therapy; Creatine Kinase; Dibenzothiazepines; Diseases in Twins; Drug Substitution; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Neurologic Examination; Olanzapine; Piperazines; Quetiapine Fumarate; Recurrence; Schizophrenia; Thiazoles | 2013 |
Catatonia and parkinsonism as a sequelae of typhoid fever: a rare experience.
Topics: Adolescent; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Catatonia; Humans; Hypnotics and Sedatives; Lorazepam; Male; Olanzapine; Parkinsonian Disorders; Pramipexole; Typhoid Fever | 2013 |